On Thursday, Shares of United States Steel Corporation (NYSE:X), gained 2.64% to $12.61.
United States Steel Corporation, declared it is examining a consolidation of its North American Flat-Rolled operations and may temporarily idle its Granite City Works steelmaking operations and most finishing operations in Granite City, Ill. As the primary flat-roll supplier of Lone Star Tubular Operations, the consolidation is part of an on-going adjustment of steelmaking operations throughout North America to match customer demands.
The company routinely adjusts production at its operating facilities to reflect market fluctuations. The potential consolidation is a result of continued challenging global market conditions counting fluctuating oil prices, reduced rig counts, depressed steel prices and unfairly traded imports. These global influences continue to have a note worthy impact on the business. The company will be working closely with its customers and will continue to operate its steelmaking operations in Indiana, Michigan and Pennsylvania.
As part of the possible consolidation, 2,000 employees at Granite City Works are being issued notices under the Worker Adjustment and Retraining Notification (WARN) Act. These notices will be issued starting on Oct. 6 and are separate from formerly issued notices.
United States Steel Corporation produces and sells flat-rolled and tubular steel products in North America and Europe. It operates through three segments: Flat-Rolled Products (Flat-Rolled), U. S. Steel Europe (USSE), and Tubular Products (Tubular).
Shares of American Eagle Outfitters (NYSE:AEO), inclined 4.36% to $16.05, during its last trading session.
American Eagle Outfitters, has market worth of $3.14B while 195.43M shares were outstanding. The company offered net profit margin of 3.90% while its gross profit margin was 36.20%. ROE was recorded as 11.60% while beta factor was 0.70. The stock has shown 3.40% volatility for the week while for the month it is maintained at 3.27%.
American Eagle Outfitters, Inc. operates as a retailer of apparel and accessories in the United States and internationally. The company’s stores offers denims, pants, shorts, sweaters, fleece, outerwear, graphic T-shirts, footwear, and accessories for 15 to 25 year old men and women under the American Eagle Outfitters brand name; and intimates and personal care products for women the aerie brand name.
Finally, Amgen, Inc. (NASDAQ:AMGN), ended its last trade with 1.25% gain, and closed at $149.90.
Amgen, declared that Express Scripts will provide access to Repatha (evolocumab) through its national formulary.
“Ensuring access to Repatha for appropriate patients is among Amgen’s highest precedingities,” said Anthony C. Hooper, executive vice president of Global Commercial Operations at Amgen. “We are delighted that Express Scripts has chosen to preserve physician and patient treatment choice for patients who need intensive and predictable LDL lowering. This is an important milestone for patients. We will continue to engage constructively with other payers to enable patients to have access to Repatha.”
Repatha, approved by the U.S. Food and Drug Administration on Aug. 27, is indicated as an adjunct to diet and maximally tolerated statin therapy for the treatment of adults with heterozygous familial hypercholesterolemia (HeFH) or clinical atherosclerotic cardiovascular disease (ASCVD), who require additional lowering of low-density lipoprotein cholesterol (LDL-C); and as an adjunct to diet and other LDL-lowering therapies for the treatment of patients with homozygous familial hypercholesterolemia (HoFH), who require additional lowering of LDL-C. The effect of Repatha on cardiovascular morbidity and mortality has not been determined.
Amgen Inc., a biotechnology company, discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses for the treatment of illness in the areas of oncology, hematology, inflammation, bone health, nephrology, cardiovascular, and general medicine.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
